Australia markets closed

ANIK Jun 2024 15.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
10.850.00 (0.00%)
At close: 09:30AM EDT
Full screen
Previous close10.85
OpenN/A
Bid10.40
Ask14.00
Strike15.00
Expiry date2024-06-21
Day's range7.90 - 10.85
Contract rangeN/A
VolumeN/A
Open interest1
  • GlobeNewswire

    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3, 2024, Anika granted: (i) non-statutory stock options (“Options”) covering 96,525 shares of common stock at a per share exercise price of $29.35, which equaled 110% of the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, and (ii) restricted stock units (

  • GlobeNewswire

    Anika Enters into Cooperation Agreement with Caligan Partners

    Appoints Joseph Capper and William Jellison to Board of DirectorsAnnounces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has entered into a cooperation agreement with Caligan Partners LP (“Caligan”). As part of the agreement, Joseph Capper, CEO of MIMEDX, and William Jellison, former CFO of Stryker, have been appointed

  • Simply Wall St.

    Anika Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

    Anika Therapeutics ( NASDAQ:ANIK ) First Quarter 2024 Results Key Financial Results Revenue: US$40.5m (up 6.9% from 1Q...